Literature DB >> 3669008

Carbamate ester derivatives as potential prodrugs of the presynaptic dopamine autoreceptor agonist (-)-3-(3-hydroxyphenyl)-N-propylpiperidine.

S O Thorberg1, S Berg, J Lundström, B Pettersson, A Wijkström, D Sanchez, P Lindberg, J L Nilsson.   

Abstract

Twenty derivatives bearing substituents on the phenolic function of (-)-3-(3-hydroxyphenyl)-N-propylpiperidine [(-)-3-PPP] were synthesized and tested as prodrugs. The carbamate ester derivatives were found to be the most suitable prodrugs, and especially the 4-isopropylphenylcarbamate 20 was capable of escaping the first-pass metabolism and still generating high plasma levels of the parent compound. Four hours after an oral dose of 100 mumol/kg to rats, a plasma level of 2400 nmol/L of (-)-3-PPP was detected by an HPLC method. This was 90 times the level reached after 4 h (27 nmol/L) when (-)-3-PPP itself was given orally at the same dose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3669008     DOI: 10.1021/jm00394a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Stan L Banks; Jianhong Chen; Dana C Hammell; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

2.  Improvement of the oral bioavailability of the selective dopamine agonist N-0437 in rats: the in vitro and in vivo activity of eight ester prodrugs.

Authors:  I den Daas; P G Tepper; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

3.  Investigating the spectrum of biological activity of ring-substituted salicylanilides and carbamoylphenylcarbamates.

Authors:  Jan Otevrel; Zuzana Mandelova; Matus Pesko; Jiahui Guo; Katarina Kralova; Frantisek Sersen; Marcela Vejsova; Danuta S Kalinowski; Zaklina Kovacevic; Aidan Coffey; Jozef Csollei; Des R Richardson; Josef Jampilek
Journal:  Molecules       Date:  2010-11-10       Impact factor: 4.411

Review 4.  Antiparkinson prodrugs.

Authors:  Antonio Di Stefano; Piera Sozio; Laura Serafina Cerasa
Journal:  Molecules       Date:  2008-01-16       Impact factor: 4.411

Review 5.  Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis.

Authors:  Giovanni Stelitano; José Camilla Sammartino; Laurent Roberto Chiarelli
Journal:  Molecules       Date:  2020-03-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.